Therapeutic Associations Comprising Anti-PD-1/PD-L1 in Breast Cancer: Clinical Challenges and Perspectives

SIMPLE SUMMARY: Breast cancer remains the leading cause of death in women. Despite improved treatment in recent years, new therapeutic options are still needed for some types of breast cancer. In view of the poor response of breast cancer to immunotherapy, it is important to develop therapeutic comb...

Descripción completa

Detalles Bibliográficos
Autores principales: Ledys, Fanny, Kalfeist, Laura, Galland, Loick, Limagne, Emeric, Ladoire, Sylvain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656936/
https://www.ncbi.nlm.nih.gov/pubmed/34885109
http://dx.doi.org/10.3390/cancers13235999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656936/
https://www.ncbi.nlm.nih.gov/pubmed/34885109
http://dx.doi.org/10.3390/cancers13235999

Ejemplares similares